Keyhole limpet hemocyanin

DB05299ApprovedInvestigationalWithdrawnProtein Based Therapies

Keyhole limpet hemocyanin is an immune modulator, given as a vaccine to help the body respond to cancer. A natural protein isolated from the marine mollusc keyhole limpet. Keyhole limpet... Keyhole limpet hemocyanin is an immunogenic carrier protein that, in vivo, increases antigenic immune responses to haptens and other weak antigens such as idiotype proteins.

Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in bladder cancer and solid tumors.Curator reviewed

Resolves to

Targets

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
41Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Keyhole limpet hemocyanin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account